Transcriptome-based biomarker prediction for Parkinson’s disease using genome-scale metabolic modeling
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Transcriptome-based biomarker prediction for Parkinson’s disease using genome-scale metabolic modeling ; volume:14 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-15 ; date:12.2024
Scientific reports ; 14, Heft 1 (5.1.2024), 1-15, 12.2024
- Creator
-
Abdik, Ecehan
Çakır, Tunahan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-51034-y
- URN
-
urn:nbn:de:101:1-2024031821592365489932
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abdik, Ecehan
- Çakır, Tunahan
- SpringerLink (Online service)
Other Objects (12)
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Biomarker discovery in Multiple Sclerosis and Parkinson's disease : novel insights into metabolic desease mechanismus
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Biomarker discovery in Multiple Sclerosis and Parkinson's disease : novel insights into metabolic desease mechanismus
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Biomarker discovery in Multiple Sclerosis and Parkinson's disease : novel insights into metabolic desease mechanismus
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease